These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 38022651)
1. Serum protein biomarkers for HCC risk prediction in HIV/HBV co-infected people: a clinical proteomic study using mass spectrometry. Ke H; Yuan R; Liu H; Luo M; Hu H; Zhang E; Zhuang K; Yang Y; Yang R Front Immunol; 2023; 14():1282469. PubMed ID: 38022651 [TBL] [Abstract][Full Text] [Related]
2. External validation of the PAGE-B score for HCC risk prediction in people living with HIV/HBV coinfection. Surial B; Ramírez Mena A; Roumet M; Limacher A; Smit C; Leleux O; Mocroft A; van der Valk M; Bonnet F; Peters L; Rockstroh JK; Günthard HF; Berzigotti A; Rauch A; Wandeler G; ; ; ; J Hepatol; 2023 May; 78(5):947-957. PubMed ID: 36690280 [TBL] [Abstract][Full Text] [Related]
3. Differential proteomic analysis of plasma-derived exosomes as diagnostic biomarkers for chronic HBV-related liver disease. Ye B; Shen Y; Chen H; Lin S; Mao W; Dong Y; Li X Sci Rep; 2022 Aug; 12(1):14428. PubMed ID: 36002595 [TBL] [Abstract][Full Text] [Related]
4. A novel plasma proteomic-based model for predicting liver fibrosis in HIV/HBV co-infected adults. Yuan R; Zhang Y; Deng L; Yu X; Zhuang K; Chen X; Cao Q; Ping H; Ke H; Gui X; Yang R J Med Virol; 2023 Jan; 95(1):e28222. PubMed ID: 36237173 [TBL] [Abstract][Full Text] [Related]
5. [Bioinformatics analysis of core differentially expressed genes in hepatitis B virus-related hepatocellular carcinoma]. Yu Y; Cheng J; Mei CZ; Dai YZ Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2022 Nov; 34(5):507-513. PubMed ID: 36464255 [TBL] [Abstract][Full Text] [Related]
6. Identification and validation of three core genes in p53 signaling pathway in hepatitis B virus-related hepatocellular carcinoma. Yu M; Xu W; Jie Y; Pang J; Huang S; Cao J; Gong J; Li X; Chong Y World J Surg Oncol; 2021 Mar; 19(1):66. PubMed ID: 33685467 [TBL] [Abstract][Full Text] [Related]
7. Proteome Differences between Hepatitis B Virus Genotype-B- and Genotype-C-Induced Hepatocellular Carcinoma Revealed by iTRAQ-Based Quantitative Proteomics. Wei D; Zeng Y; Xing X; Liu H; Lin M; Han X; Liu X; Liu J J Proteome Res; 2016 Feb; 15(2):487-98. PubMed ID: 26709725 [TBL] [Abstract][Full Text] [Related]
8. Screening differential expression of serum proteins in AFP-negative HBV-related hepatocellular carcinoma using iTRAQ -MALDI-MS/MS. He X; Wang Y; Zhang W; Li H; Luo R; Zhou Y; Liao CL; Huang H; Lv X; Xie Z; He M Neoplasma; 2014; 61(1):17-26. PubMed ID: 24195504 [TBL] [Abstract][Full Text] [Related]
9. Screening and Functional Prediction of Key Candidate Genes in Hepatitis B Virus-Associated Hepatocellular Carcinoma. Chen X; Liao L; Li Y; Huang H; Huang Q; Deng S Biomed Res Int; 2020; 2020():7653506. PubMed ID: 33102593 [TBL] [Abstract][Full Text] [Related]
10. Bioinformatics analysis of key biomarkers and potential molecular mechanisms in hepatocellular carcinoma induced by hepatitis B virus. Li Z; Xu J; Cui H; Song J; Chen J; Wei J Medicine (Baltimore); 2020 May; 99(20):e20302. PubMed ID: 32443377 [TBL] [Abstract][Full Text] [Related]
11. Exploring new targets for the treatment of hepatitis-B virus and hepatitis-B virus-associated hepatocellular carcinoma: A new perspective in bioinformatics. Wang Y; Wang S; Che Y; Chen D; Liu Y; Shi Y Medicine (Baltimore); 2021 Aug; 100(33):e26917. PubMed ID: 34414947 [TBL] [Abstract][Full Text] [Related]
12. Significance of Identifying Key Genes Involved in HBV-Related Hepatocellular Carcinoma for Primary Care Surveillance of Patients with Cirrhosis. Li Y; Li J; He T; Song Y; Wu J; Wang B Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553600 [TBL] [Abstract][Full Text] [Related]
13. Quantitative proteomic analysis of gingival crevicular fluids to identify novel biomarkers of gingival recession in orthodontic patients. Pei F; Wang M; Wang Y; Pan X; Cen X; Huang X; Jin Y; Zhao Z J Proteomics; 2022 Aug; 266():104647. PubMed ID: 35779762 [TBL] [Abstract][Full Text] [Related]
14. Microarray Data Mining and Preliminary Bioinformatics Analysis of Hepatitis D Virus-Associated Hepatocellular Carcinoma. Yu Z; Ma X; Zhang W; Chang X; An L; Niu M; Chen Y; Sun C; Yang Y Biomed Res Int; 2021; 2021():1093702. PubMed ID: 33564675 [TBL] [Abstract][Full Text] [Related]
15. Blood-Based Biomarkers in Hepatitis B Virus-Related Hepatocellular Carcinoma, Including the Viral Genome and Glycosylated Proteins. Hayashi S; Nagaoka K; Tanaka Y Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681709 [TBL] [Abstract][Full Text] [Related]
16. Hepatocellular carcinoma: Clinical-pathological features and HIV infection in Mozambican patients. Cunha L; Carrilho C; Bhatt N; Loforte M; Maueia C; Fernandes F; Guisseve A; Mbofana F; Maibaze F; Mondlane L; Ismail M; Dimande L; Machatine S; Lunet N; Liu YT; Gudo ES; Pineau P Cancer Treat Res Commun; 2019; 19():100129. PubMed ID: 30903933 [TBL] [Abstract][Full Text] [Related]
17. Proteomic analysis of differentially expressed proteins in hepatitis B virus-related hepatocellular carcinoma tissues. Li N; Long Y; Fan X; Liu H; Li C; Chen L; Wang Z J Exp Clin Cancer Res; 2009 Aug; 28(1):122. PubMed ID: 19715608 [TBL] [Abstract][Full Text] [Related]
18. Identification of Potential Hub Genes Related to Diagnosis and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma via Integrated Bioinformatics Analysis. Tang Y; Zhang Y; Hu X Biomed Res Int; 2020; 2020():4251761. PubMed ID: 33376723 [TBL] [Abstract][Full Text] [Related]
19. Targeted Proteins Reveal Cathepsin D as a Novel Biomarker in Differentiating Hepatocellular Carcinoma from Cirrhosis and Other Liver Cancers. Chuaypen N; Sriphoosanaphan S; Vorasittha A; Pinjaroen N; Chaiyarit S; Thongboonkerd V; Tangkijvanich P; Sirichindakul P Asian Pac J Cancer Prev; 2022 Jun; 23(6):2017-2025. PubMed ID: 35763644 [TBL] [Abstract][Full Text] [Related]
20. Discovery of candidate biomarkers from plasma-derived extracellular vesicles of patients with cirrhosis and hepatocellular carcinoma: an exploratory proteomic study. Zertuche-Martínez C; Velázquez-Enríquez JM; González-García K; Santos-Álvarez JC; Romero-Tlalolini MLÁ; Pina-Canseco S; Pérez-Campos Mayoral L; Muriel P; Villa-Treviño S; Baltiérrez-Hoyos R; Arellanes-Robledo J; Vásquez-Garzón VR Mol Omics; 2024 Aug; 20(7):483-495. PubMed ID: 39011654 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]